Dutasteride and Topiramate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dutasteride (dutasteride) and Topiramate (topiramate). Common drug interactions include surgery among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Dutasteride and Topiramate. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Dutasteride?

Dutasteride has active ingredients of dutasteride. It is often used in prostate examination abnormal. eHealthMe is studying from 8,205 Dutasteride users. Check the latest studies of Dutasteride.

What is Topiramate?

Topiramate has active ingredients of topiramate. It is often used in migraine. eHealthMe is studying from 49,809 Topiramate users. Check the latest studies of Topiramate.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 29, 2026

19 people who take Dutasteride and Topiramate together, and have interactions are studied.

Dutasteride and Topiramate drug interactions.

What are the common drug interactions of Dutasteride and Topiramate, by gender? *:

female:

  1. Surgery
  2. Blindness transient (sudden loss of vision)
  3. Dyspnoea (difficult or laboured respiration)
  4. Headache (pain in head)
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

male:

  1. Abdominal distension
  2. Epistaxis (bleed from the nose)
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Dysstasia (difficulty in standing)
  5. Erythema (redness of the skin)
  6. Heart rate irregular
  7. Hepatic haematoma (collection of blood outside of blood vessels in liver)
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Hypotension (abnormally low blood pressure)
  10. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)

What are the common drug interactions of Dutasteride and Topiramate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Surgery

50-59:

  1. Abdominal pain upper
  2. Chest pain
  3. Dyspnoea (difficult or laboured respiration)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Nausea (feeling of having an urge to vomit)
  6. Tinnitus (a ringing in the ears)

60+:

  1. Asthenia (weakness)
  2. Blindness transient (sudden loss of vision)
  3. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  4. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  5. Palpitations (feelings or sensations that your heart is pounding or racing)
  6. Presyncope
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  9. Tremor (trembling or shaking movements in one or more parts of your body)
  10. Drug ineffective

What are the existing conditions these people have? *

  1. Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 3 people, 15.79%
  2. Parkinson's Disease: 3 people, 15.79%
  3. Pain: 2 people, 10.53%
  4. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
  5. Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 1 person, 5.26%
  6. Hair Loss: 1 person, 5.26%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%
  8. Gastritis (inflammation of stomach): 1 person, 5.26%
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 1 person, 5.26%
  10. Drowsiness: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Dutasteride and Topiramate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dutasteride and Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dutasteride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Topiramate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dutasteride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Topiramate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dutasteride and topiramate (the active ingredients of Dutasteride and Topiramate, respectively), and Dutasteride and Topiramate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: